Sfoglia per Autore
ERBB RECEPTORS DIMERIZATION DEFINES BREAST CANCERS SUBTYPES AND CLINICAL OUTCOMES: IMPLICATION FOR CANCER THERAPIES
2016 Nicoletta Macrì, Valerio Gelfo, Davide D’Urso, Massimiliano Bonafè, Mattia Lauriola, Adriana Albini, D’Uva Gabriele
Mechanisms of acquired resistance to cetuximab: role of interleukin 1
2016 Valerio Gelfo, Michela Pucci, Moshit Lindzen, Maria Teresa Rodia, Rossella Solmi, Massimiliano Bonafè, Elisabetta Caramelli, Yosef Yarden, Mattia Lauriola.
A module of inflammatory cytokines defines resistance of colorectal cancer to EGFR inhibitors
2016 Gelfo, Valerio; Rodia, Maria Teresa; Pucci, Michela; Dall'Ora, Massimiliano; Santi, Spartaco; Solmi, Rossella; Roth, Lee; Lindzen, Moshit; Bonafè, Massimiliano; Bertotti, Andrea; Caramelli, Elisabetta; Lollini, Pier-Luigi; Trusolino, Livio; Yarden, Yosef; D'Uva, Gabriele; Lauriola, Mattia
Circular RNAs are long-lived and display only minimal early alterations in response to a growth factor
2016 Enuka, Yehoshua; Lauriola, Mattia; Feldman, Morris E.; Sas-Chen, Aldema; Ulitsky, Igor; Yarden, Yosef
Towards the emerging crosstalk: ERBB family and steroid hormones
2016 D'Uva, Gabriele; Lauriola, Mattia
Adenomatous polyposis coli (APC) regulates miR17-92 cluster through β-catenin pathway in colorectal cancer
2016 Li, Y; Lauriola, M.; Kim, D.; Francesconi, M.; D’Uva, G.; Shibata, D.; Malafa, M.P.; Yeatman, T.J.; Coppola, D.; Solmi, R.; Cheng, J.Q.
An antibody to amphiregulin, an abundant growth factor in patients' fluids, inhibits ovarian tumors
2016 Carvalho, S.; Lindzen, M.; Lauriola, M.; Shirazi, N.; Sinha, S.; Abdul-Hai, A.; Levanon, K.; Korach, J.; Barshack, I.; Cohen, Y.; Onn, A.; Mills, G.; Yarden, Y
Systematic large-scale meta-analysis identifies a panel of two mRNAs as blood biomarkers for colorectal cancer detection
2016 Rodia, Maria Teresa; Ugolini, Giampaolo; Mattei, Gabriella; Montroni, Isacco; Zattoni, Davide; Ghignone, Federico; Veronese, Giacomo; Marisi, Giorgia; Lauriola, Mattia; Strippoli, Pierluigi; Solmi, Rossella
Unveiling the role of interleukine-1 Receptor in response to EGFR blockade
2017 Valerio Gelfo, Moshit Lindzen, Martina Mazzeschi, Giada Grilli, Rossella Solmi, Balazs Győrffy, Gabriele D’Uva, Yosef Yarden, Mattia Lauriola
Mechanisms of acquired resistance to cetuximab: role of interleukin-1
2017 Valerio Gelfo, Michela Pucci, Moshit Lindzen, Maria Teresa Rodia, Rossella Solmi, Massimiliano Bonafè, Elisabetta Caramelli, Yosef Yarden, Mattia Lauriola
Mechanisms of acquired resistance to cetuximab: role of interleukin-1
2017 Valerio Gelfo, Michela Pucci, Moshit Lindzen, Martina Mazzeschi, Massimiliano Bonafè, Rossella Solmi, Gabriele D’Uva, Yosef Yarden, Mattia Lauriola
A putative role for interleukin 1 pathway in resistance to EGFR blockade
2017 Valerio Gelfo, Martina Mazzeschi, Giada Grilli, Moshit Lindzen, Rossella Solmi, Gabriele D’Uva, Yosef Yarden, Mattia Lauriola
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone
2017 Enuka, Yehoshua; Feldman, Morris E; Chowdhury, Animesh; Srivastava, Swati; Lindzen, Moshit; Sas-Chen, Aldema; Massart, Renaud; Cheishvili, David; Suderman, Matthew J; Zaltsman, Yoav; Mazza, Chiara A; Shukla, Kirti; Körner, Cindy; Furth, Noa; Lauriola, Mattia; Oren, Moshe; Wiemann, Stefan; Szyf, Moshe; Yarden, Yosef
A novel role for interleukin 1 axis in the resistance to EGFR targeting antibody
2018 Valerio Gelfo, Michela Sgarzi, Maria Mazzarini, Francesca Pontis, Gabriele D’Uva, Balanz Győrffy, Yosef Yarden, Mattia Lauriola
Modulation of ERBB signaling from tissue homeostasis to cancer progression
2018 Valerio Gelfo, Giada Grilli, Martina Mazzeschi, Moshit Lindzen, Rossella Solmi, Gabriele. D’Uva, Balazs. Győrffy, Yosef Yarden, Mattia Lauriola.
Molecular mechanisms of resistance to cetuximab mediated by IL-1 signaling
2018 Valerio Gelfo, Giada Grilli, Martina Mazzeschi, Moshit Lindzen, Spartaco Santi, Gabriele D’Uva, Yosef Yarden, Mattia Lauriola
LGALS4, CEACAM6, TSPAN8, and COL1A2: Blood Markers for Colorectal Cancer-Validation in a Cohort of Subjects With Positive Fecal Immunochemical Test Result
2018 Rodia, Maria Teresa; Solmi, Rossella; Pasini, Francesco; Nardi, Elena; Mattei, Gabriella; Ugolini, Giampaolo; Ricciardiello, Luigi; Strippoli, Pierluigi; Miglio, Rossella; Lauriola, Mattia
SILAC identifies LAD1 as a filamin-binding regulator of actin dynamics in response to EGF and a marker of aggressive breast tumors
2018 Roth, Lee; Srivastava, Swati; Lindzen, Moshit; Sas-Chen, Aldema; Sheffer, Michal; Lauriola, Mattia; Enuka, Yehoshua; Noronha, Ashish; Mancini, Maicol; Lavi, Sara; Tarcic, Gabi; Pines, Gur; Nevo, Nava; Heyman, Ori; Ziv, Tamar; Rueda, Oscar M.; Gnocchi, Davide; Pikarski, Eli; Admon, Arie; Caldas, Carlos; Yarden, Yosef*
A Novel Role for the Interleukin-1 Receptor Axis in Resistance to Anti-EGFR Therapy
2018 Gelfo V, Mazzeschi M, Grilli G, Lindzen Moshit, Santi Spartaco, D'Uva G, Győrffy B, Ardizzoni A, Yarden Y, Lauriola M.
ETS Proteins Bind with Glucocorticoid Receptors: Relevance for Treatment of Ewing Sarcoma
2019 Srivastava S.; Nataraj N.B.; Sekar A.; Ghosh S.; Bornstein C.; Drago-Garcia D.; Roth L.; Romaniello D.; Marrocco I.; David E.; Gilad Y.; Lauriola M.; Rotkopf R.; Kimchi A.; Haga Y.; Tsutsumi Y.; Mirabeau O.; Surdez D.; Zinovyev A.; Delattre O.; Kovar H.; Amit I.; Yarden Y.
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
---|---|---|---|---|---|---|
ERBB RECEPTORS DIMERIZATION DEFINES BREAST CANCERS SUBTYPES AND CLINICAL OUTCOMES: IMPLICATION FOR CANCER THERAPIES | Nicoletta Macrì, Valerio Gelfo, Davide D’Urso, Massimiliano Bonafè, Mattia Lauriola, Adriana Albi...ni, D’Uva Gabriele | 2016-01-01 | - | - | 4.03 Poster | - |
Mechanisms of acquired resistance to cetuximab: role of interleukin 1 | Valerio Gelfo, Michela Pucci, Moshit Lindzen, Maria Teresa Rodia, Rossella Solmi, Massimiliano Bo...nafè, Elisabetta Caramelli, Yosef Yarden, Mattia Lauriola. | 2016-01-01 | - | - | 4.01 Contributo in Atti di convegno | - |
A module of inflammatory cytokines defines resistance of colorectal cancer to EGFR inhibitors | Gelfo, Valerio; Rodia, Maria Teresa; Pucci, Michela; Dall'Ora, Massimiliano; Santi, Spartaco; Sol...mi, Rossella; Roth, Lee; Lindzen, Moshit; Bonafè, Massimiliano; Bertotti, Andrea; Caramelli, Elisabetta; Lollini, Pier-Luigi; Trusolino, Livio; Yarden, Yosef; D'Uva, Gabriele; Lauriola, Mattia | 2016-01-01 | ONCOTARGET | - | 1.01 Articolo in rivista | 2016 - Gelfo Oncotarget 2016.pdf |
Circular RNAs are long-lived and display only minimal early alterations in response to a growth factor | Enuka, Yehoshua; Lauriola, Mattia; Feldman, Morris E.; Sas-Chen, Aldema; Ulitsky, Igor; Yarden, Y...osef | 2016-01-01 | NUCLEIC ACIDS RESEARCH | - | 1.01 Articolo in rivista | 2015 - Nucl. Acids Res.-2015-Enuka-nar-gkv1367.pdf |
Towards the emerging crosstalk: ERBB family and steroid hormones | D'Uva, Gabriele; Lauriola, Mattia | 2016-01-01 | SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY | - | 1.01 Articolo in rivista | - |
Adenomatous polyposis coli (APC) regulates miR17-92 cluster through β-catenin pathway in colorectal cancer | Li, Y; Lauriola, M.; Kim, D.; Francesconi, M.; D’Uva, G.; Shibata, D.; Malafa, M.P.; Yeatman, T.J....; Coppola, D.; Solmi, R.; Cheng, J.Q. | 2016-01-01 | ONCOGENE | - | 1.01 Articolo in rivista | nihms-742084.pdf |
An antibody to amphiregulin, an abundant growth factor in patients' fluids, inhibits ovarian tumors | Carvalho, S.; Lindzen, M.; Lauriola, M.; Shirazi, N.; Sinha, S.; Abdul-Hai, A.; Levanon, K.; Kora...ch, J.; Barshack, I.; Cohen, Y.; Onn, A.; Mills, G.; Yarden, Y | 2016-01-01 | ONCOGENE | - | 1.01 Articolo in rivista | - |
Systematic large-scale meta-analysis identifies a panel of two mRNAs as blood biomarkers for colorectal cancer detection | Rodia, Maria Teresa; Ugolini, Giampaolo; Mattei, Gabriella; Montroni, Isacco; Zattoni, Davide; Gh...ignone, Federico; Veronese, Giacomo; Marisi, Giorgia; Lauriola, Mattia; Strippoli, Pierluigi; Solmi, Rossella | 2016-01-01 | ONCOTARGET | - | 1.01 Articolo in rivista | Oncotarget 8108-123292-2-PB.pdf; oncotarget-07-30295-s002.zip |
Unveiling the role of interleukine-1 Receptor in response to EGFR blockade | Valerio Gelfo, Moshit Lindzen, Martina Mazzeschi, Giada Grilli, Rossella Solmi, Balazs Győrffy, G...abriele D’Uva, Yosef Yarden, Mattia Lauriola | 2017-01-01 | - | - | 4.03 Poster | - |
Mechanisms of acquired resistance to cetuximab: role of interleukin-1 | Valerio Gelfo, Michela Pucci, Moshit Lindzen, Maria Teresa Rodia, Rossella Solmi, Massimiliano Bo...nafè, Elisabetta Caramelli, Yosef Yarden, Mattia Lauriola | 2017-01-01 | - | - | 4.01 Contributo in Atti di convegno | - |
Mechanisms of acquired resistance to cetuximab: role of interleukin-1 |
Valerio Gelfo, Michela Pucci, Moshit Lindzen, Martina Mazzeschi, Massimiliano Bonafè, Rossella S...olmi, Gabriele D’Uva, Yosef Yarden, Mattia Lauriola |
2017-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
A putative role for interleukin 1 pathway in resistance to EGFR blockade | Valerio Gelfo, Martina Mazzeschi, Giada Grilli, Moshit Lindzen, Rossella Solmi, Gabriele D’Uva, Y...osef Yarden, Mattia Lauriola | 2017-01-01 | - | - | 4.01 Contributo in Atti di convegno | - |
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone | Enuka, Yehoshua; Feldman, Morris E; Chowdhury, Animesh; Srivastava, Swati; Lindzen, Moshit; Sas-C...hen, Aldema; Massart, Renaud; Cheishvili, David; Suderman, Matthew J; Zaltsman, Yoav; Mazza, Chiara A; Shukla, Kirti; Körner, Cindy; Furth, Noa; Lauriola, Mattia; Oren, Moshe; Wiemann, Stefan; Szyf, Moshe; Yarden, Yosef | 2017-01-01 | NUCLEIC ACIDS RESEARCH | - | 1.01 Articolo in rivista | genome.pdf |
A novel role for interleukin 1 axis in the resistance to EGFR targeting antibody | Valerio Gelfo, Michela Sgarzi, Maria Mazzarini, Francesca Pontis, Gabriele D’Uva, Balanz Győrffy..., Yosef Yarden, Mattia Lauriola | 2018-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
Modulation of ERBB signaling from tissue homeostasis to cancer progression | Valerio Gelfo, Giada Grilli, Martina Mazzeschi, Moshit Lindzen, Rossella Solmi, Gabriele. D’Uva, ...Balazs. Győrffy, Yosef Yarden, Mattia Lauriola. | 2018-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
Molecular mechanisms of resistance to cetuximab mediated by IL-1 signaling | Valerio Gelfo, Giada Grilli, Martina Mazzeschi, Moshit Lindzen, Spartaco Santi, Gabriele D’Uva, Y...osef Yarden, Mattia Lauriola | 2018-01-01 | - | - | 4.01 Contributo in Atti di convegno | - |
LGALS4, CEACAM6, TSPAN8, and COL1A2: Blood Markers for Colorectal Cancer-Validation in a Cohort of Subjects With Positive Fecal Immunochemical Test Result | Rodia, Maria Teresa; Solmi, Rossella; Pasini, Francesco; Nardi, Elena; Mattei, Gabriella; Ugolini..., Giampaolo; Ricciardiello, Luigi; Strippoli, Pierluigi; Miglio, Rossella; Lauriola, Mattia | 2018-01-01 | CLINICAL COLORECTAL CANCER | - | 1.01 Articolo in rivista | Rodia2018.pdf |
SILAC identifies LAD1 as a filamin-binding regulator of actin dynamics in response to EGF and a marker of aggressive breast tumors | Roth, Lee; Srivastava, Swati; Lindzen, Moshit; Sas-Chen, Aldema; Sheffer, Michal; Lauriola, Matti...a; Enuka, Yehoshua; Noronha, Ashish; Mancini, Maicol; Lavi, Sara; Tarcic, Gabi; Pines, Gur; Nevo, Nava; Heyman, Ori; Ziv, Tamar; Rueda, Oscar M.; Gnocchi, Davide; Pikarski, Eli; Admon, Arie; Caldas, Carlos; Yarden, Yosef* | 2018-01-01 | SCIENCE SIGNALING | - | 1.01 Articolo in rivista | - |
A Novel Role for the Interleukin-1 Receptor Axis in Resistance to Anti-EGFR Therapy | Gelfo V, Mazzeschi M, Grilli G, Lindzen Moshit, Santi Spartaco, D'Uva G, Győrffy B, Ardizzoni A, ...Yarden Y, Lauriola M. | 2018-01-01 | CANCERS | - | 1.01 Articolo in rivista | - |
ETS Proteins Bind with Glucocorticoid Receptors: Relevance for Treatment of Ewing Sarcoma | Srivastava S.; Nataraj N.B.; Sekar A.; Ghosh S.; Bornstein C.; Drago-Garcia D.; Roth L.; Romaniel...lo D.; Marrocco I.; David E.; Gilad Y.; Lauriola M.; Rotkopf R.; Kimchi A.; Haga Y.; Tsutsumi Y.; Mirabeau O.; Surdez D.; Zinovyev A.; Delattre O.; Kovar H.; Amit I.; Yarden Y. | 2019-01-01 | CELL REPORTS | - | 1.01 Articolo in rivista | 2019 - Swati.pdf |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile